Rapt Therapeutics, Inc. (RAPT)
57.94
+0.02
(+0.03%)
USD |
NASDAQ |
Feb 25, 12:08
Rapt Therapeutics Research and Development Expense (Quarterly) : 12.03M for Sept. 30, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Penumbra, Inc. | 20.37M |
| Amicus Therapeutics, Inc. | 23.74M |
| Johnson & Johnson | 4.268B |
| Merck & Co., Inc. | 3.992B |
| Pfizer Inc. | 3.206B |